$500.6 M

IPHS Mkt cap, 04-Dec-2018

$196.9 M

Innophos Revenue Q3, 2018
Innophos Gross profit (Q3, 2018)35.2 M
Innophos Gross profit margin (Q3, 2018), %17.9%
Innophos Net income (Q3, 2018)14.1 M
Innophos EBIT (Q3, 2018)14.5 M
Innophos Cash, 30-Sep-201823.1 M

Innophos Revenue

Innophos revenue was $722.02 m in FY, 2017

Embed Graph

Innophos Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

844.1m839.2m789.1m725.3m722.0m

Revenue growth, %

(1%)(6%)(8%)

Cost of goods sold

685.8m651.7m645.8m575.0m573.0m

Gross profit

158.3m187.5m143.3m150.4m149.0m

Gross profit Margin, %

19%22%18%21%21%

General and administrative expense

70.5m87.3m67.6m82.2m

Operating expense total

74.4m91.8m71.3m86.0m

EBIT

83.9m106.8m51.5m79.1m63.1m

EBIT margin, %

10%13%7%11%9%

Interest expense

4.4m4.4m7.5m7.7m7.0m

Pre tax profit

76.2m97.4m40.1m70.3m56.6m

Income tax expense

26.7m32.9m13.8m22.3m34.2m

Net Income

49.5m64.5m26.3m48.0m22.4m

Innophos Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

32.8m36.2m17.9m53.5m28.8m

Accounts Receivable

88.4m90.6m79.7m77.7m100.8m

Inventories

181.5m184.6m172.7m128.3m145.7m

Current Assets

384.1m371.5m293.8m283.4m300.3m

PP&E

202.0m199.0m199.5m205.5m219.3m

Goodwill

84.4m84.4m84.4m84.4m152.7m

Total Assets

745.2m728.4m669.6m643.0m785.2m

Accounts Payable

273.7m

Short-term debt

4.0m4.0m4.0m4.0k

Current Liabilities

76.8m91.9m104.1m95.2m113.5m

Long-term debt

159.0m132.0m209.0m185.0m310.0m

Total Debt

163.0m136.0m213.0m185.0m310.0m

Total Liabilities

281.8m336.3m295.8m451.6m

Additional Paid-in Capital

120.0m124.6m132.4m134.7m137.6m

Retained Earnings

364.5m390.5m378.3m389.0m374.4m

Total Equity

333.3m347.2m333.6m

Debt to Equity Ratio

0.6 x0.5 x0.9 x

Debt to Assets Ratio

0.2 x0.2 x0.3 x0.3 x0.4 x

Financial Leverage

2 x1.9 x2.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

35.8m43.3m38.5m45.2m57.2m80.0m86.0m15.4m39.2m32.8m29.8m33.5m32.7m40.7m12.3m23.1m

Accounts Receivable

99.2m107.1m107.7m94.7m100.5m101.4m100.7m91.9m85.0m79.8m84.4m85.5m102.2m106.7m108.9m103.1m

Inventories

157.9m165.1m164.3m163.7m176.3m175.0m169.6m166.6m156.1m139.5m137.4m126.7m148.5m154.5m158.9m168.7m

Current Assets

371.3m391.0m379.9m382.0m396.6m402.8m404.2m305.1m298.4m273.4m279.9m275.7m308.9m326.5m309.6m329.2m

PP&E

201.6m200.7m201.7m200.0m196.7m197.0m197.1m199.4m202.3m202.9m206.3m206.7m211.6m220.6m232.5m232.4m

Goodwill

83.9m84.4m84.4m84.4m84.4m84.4m84.4m84.4m84.4m84.4m84.4m84.4m139.5m152.7m152.8m152.8m

Total Assets

730.1m749.9m737.6m737.7m748.0m752.6m751.7m677.6m672.2m644.8m637.6m631.7m770.8m809.8m801.2m820.2m

Short-term debt

4.0m4.0m4.0m4.0m4.0m4.0m4.0m4.0m4.0m4.0m

Current Liabilities

77.4m81.2m79.0m89.0m74.9m87.0m86.7m93.6m87.1m84.9m85.6m86.4m107.9m101.3m112.5m118.2m

Long-term debt

158.0m151.0m135.0m124.0m201.0m240.0m282.0m225.8m225.0m195.2m189.0m180.0m

Total Debt

162.0m155.0m139.0m128.0m205.0m244.0m286.0m229.8m229.0m199.2m189.0m180.0m

Total Liabilities

270.8m279.8m261.4m259.8m317.1m367.9m409.4m341.6m332.4m299.4m289.3m280.5m417.0m473.5m466.2m479.6m

Additional Paid-in Capital

117.5m121.4m122.3m123.7m125.2m77.8m127.8m132.1m133.5m134.5m134.5m136.0m136.6m138.6m140.4m141.5m

Retained Earnings

358.7m369.9m381.7m389.6m392.3m396.0m392.2m381.9m384.7m388.9m390.6m392.4m394.6m375.9m372.8m377.4m

Total Equity

384.7m342.4m336.0m339.8m345.4m348.3m351.1m353.8m336.2m335.0m340.7m

Debt to Equity Ratio

0.6 x0.8 x0.7 x0.7 x0.6 x0.5 x0.5 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.3 x0.4 x0.3 x0.3 x0.3 x0.3 x0.3 x

Financial Leverage

2 x2.2 x2 x2 x1.9 x1.8 x1.8 x2.2 x2.4 x2.4 x2.4 x

Innophos Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

49.5m64.5m26.3m48.0m22.4m

Depreciation and Amortization

35.5m35.5m38.5m37.5m40.4m

Accounts Receivable

5.9m(2.1m)10.8m2.1m(11.0m)

Inventories

Accounts Payable

2.2m14.2m(16.4m)14.7m3.1m

Cash From Operating Activities

5.9m3.5m(18.3m)

Cash From Investing Activities

(37.8m)(29.4m)(31.7m)(36.6m)(191.5m)

Dividends Paid

(31.8m)(38.4m)(38.6m)(37.2m)(37.5m)

Cash From Financing Activities

(47.5m)(94.0m)(86.0m)(67.1m)86.5m

Free Cash Flow

(27.5m)(50.0m)

Innophos Ratios

USDY, 2018

Financial Leverage

2.4 x
Report incorrect company information

Innophos Employee Rating

2.921 votes
Culture & Values
2.9
Work/Life Balance
3.8
Senior Management
2.7
Salary & Benefits
3.5
Career Opportunities
2.6
Sourcewdxefcqufszuzezftuxetqsqxt